Posts Tagged ‘pharmaceutical’
« Older Entries | Newer Entries »
Throwing money at Big Pharma won’t guarantee vaccine supply
Thursday, April 8th, 2021
Now we’re poised to give Sanofi hundreds of millions of taxpayer dollars in the hope of ensuring a future vaccine supply… If we really want a biotech company we can rely on and that doesn’t hold a gun to our head, we should spend our money creating an enterprise that we actually own and control – a little secret learned by Cuba and, decades earlier, by the brilliant Canadians who created Connaught.
Tags: budget, economy, globalization, Health, ideology, pharmaceutical, privatization
Posted in Health Debates | No Comments »
Canada needs the Connaught model of domestic vaccine production
Saturday, March 20th, 2021
A properly restored Canadian global powerhouse in vaccines would improve on the current world patchwork of players focused on discovery, clinical trials, safe packaging, mass production and a dozen other disciplines, layered over by conflicting priorities of national governments. That model conflicts with Ottawa’s current $1-billion national vaccine strategy.
Tags: economy, Health, ideology, pharmaceutical
Posted in Health Policy Context | No Comments »
When will the Liberal government keep its promises on national pharmacare?
Saturday, March 6th, 2021
Canadians have waited for decades for universal pharmacare. With the onset of the COVID-19 pandemic, they cannot wait any longer… The 2021 federal budget is just around the corner. If the government’s rejection of C-213 was because it was written on the terms of an opposition party and not their own, this may be one of the last opportunities for the prime minister to make good on his public support for universal, public pharmacare.
Tags: budget, economy, featured, Health, ideology, jurisdiction, mental Health, pharmaceutical, standard of living
Posted in Health Policy Context | No Comments »
Compulsory licensing would allow Ottawa to authorize generic copies of the COVID-19 vaccines
Friday, February 5th, 2021
compulsory licensing would eliminate the need for constant negotiation. The government would make its decision and that would be that. The drug giants would be furious. Pfizer and Moderna might refuse to honour their pledges. They might cut back promised shipments of the vaccine.
But they are doing that anyway. And the government has been unable to use the usual methods of contract compliance to stop them. Compulsory licensing provides government with a workable alternative…
Tags: budget, globalization, Health, pharmaceutical, privatization, standard of living
Posted in Health Policy Context | No Comments »
A broader vision of public health
Wednesday, January 27th, 2021
If we learn anything from COVID-19, it should be that we need a more comprehensive version of public health that acts on what we know about the social determinants of well-being… Here’s our three-step plan. 1. Identify the contours of an integrated, coherent vision of public health… 2. Co-ordinate the wider public health vision across political jurisdictions… 3. Work from the ground up to uncouple “health” from “health care.”
Tags: featured, Health, ideology, Indigenous, jurisdiction, participation, pharmaceutical, standard of living
Posted in Health Policy Context | No Comments »
NDP and Greens Push Trudeau to Answer Vancouver’s Call to Decriminalize Drugs
Monday, December 28th, 2020
The MPs want Hajdu to use her authority under Section 56 of the act, which grants the health minister the power to issue an exemption from any part of the legislation “for a medical or scientific purpose or is otherwise in the public interest.” … to take the supply “out of the hands of criminals and remove the stigmatization, and ensure that people get access to safe, regulated, properly packaged products. And we need to substantially beef up our prevention, education and, most importantly, treatment options for substance users.
Tags: crime prevention, disabilities, Health, ideology, pharmaceutical
Posted in Health Policy Context | No Comments »
Premiers call dibs on federal money before it’s all spent
Friday, December 11th, 2020
Health care is provincial jurisdiction. They can levy taxes like Ottawa. If they need more money, they could raise taxes… A lot of what Ottawa does is sending money to people or provinces. But health care? … Mr. Trudeau doesn’t want to just send cheques. He wants to say he paid for something new and specific that Canadians want. He told the premiers that Ottawa might fund better long-term care, or pharmacare.
Tags: budget, featured, Health, jurisdiction, pharmaceutical, tax
Posted in Governance Debates | No Comments »
We need a homegrown solution for making enough vaccines for every Canadian
Thursday, December 3rd, 2020
… pandemic preparedness… includes, at its core, an arms-length national vaccine manufacturing facility that, first and foremost, has the capacity to produce enough vaccines for every Canadian… The facility could be made available to the private sector to make large batches at cost during normal times and commandeered by the federal government for large-scale vaccine deployment during a pandemic… It would be a partnership between biopharmaceutical companies, academia and the federal government.
Tags: economy, featured, Health, ideology, pharmaceutical, standard of living
Posted in Health Policy Context | No Comments »
When Canada was a world leader in vaccine research and production
Thursday, December 3rd, 2020
… scientists are permitted to take out patents on the products they develop (with our money), and then sell them to pharmaceutical manufacturers, who sell the products to the public — often at great profit. Even though our public investment paid for the original research, Canadians have no say over the products nor the price at which they are sold to us as consumers. Canada also has no share in the profits. We’ve ventured a long way, unfortunately, from the days when we had a publicly owned and medically innovative enterprise that dazzled on the world stage and kept Canadians at the front of the line for vaccines.
Tags: Health, ideology, pharmaceutical, privatization, standard of living
Posted in Health History | No Comments »
Let’s make Canada a global leader in COVID-19 treatments
Tuesday, November 24th, 2020
Canadian-led breakthroughs in medical sciences can improve our health and well-being, bolster our universities and research hospitals, strengthen our reputation in the global competition for resources and talent, and result in economic benefits for Canadians. And, most importantly, these trials could quickly develop novel therapies for treating COVID-19 while creating the downstream benefits of infrastructure and know-how to help us discover treatments for the next pandemic as well as for other diseases.
Tags: disabilities, Health, jurisdiction, participation, pharmaceutical
Posted in Health Policy Context | No Comments »
Recent Comments